Outsourced Pharma Capacity Update Videos - Cell & Gene
-
IDT Biologika Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
With over 30 years of GMP manufacturing expertise, we offer dedicated capacity for clinical and commercial gene therapy batches, using advanced AAV platforms and proprietary cell lines.
-
SK pharmteco Capacity Update October 2024: Cell & Gene Therapy
10/24/2024
Check out our enhanced capacity and expertise in supporting CGT projects, offering end-to-end solutions from viral vector and plasmid development to GMP manufacturing and regulatory support.
-
VintaBio Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
VintaBio has created open capacity for AAV clinical manufacturing through its streamlined VintaProcess platform which is an intensified adherent AAV process with very low impurities.
-
FUJIFILM Diosynth Biotechnologies Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
The capacity expansion project at our Thousand Oaks facility will add new cleanrooms, updated development labs, expanded QC labs, and high efficiency warehousing solutions.
-
WuXi Advanced Therapies Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
Learn how our expert and experienced team in Philadelphia supports cell therapy and viral vector production across a variety of modalities and stages of clinical and commercial manufacturing.
-
Alcami Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
Alcami offers method development, method validation and QC testing, as well as R&D testing support, leveraging our company’s extensive expertise in various testing platforms.
-
Andelyn Biosciences Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
To address the myriad of challenges that accompany AAV manufacturing, Andelyn uses a combination of reductionist and holistic approaches to perform end-to-end optimization for its platform.
-
Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
In addition to the immediate capacity for Draw-to-Thaw™ services in New York, NY, and Louisville, KY, we have openings for process and analytical development work in its Houston, TX facility.
-
Cellistic Capacity Update July 2024: Cell & Gene Therapy
8/14/2024
Explore the latest insights and challenges in the cell therapy space, and learn how Cellistic overcomes these challenges with iPSC, focusing on regulatory strategies and cutting-edge capabilities.
-
ElevateBio Capacity Update July 2024: Cell & Gene Therapy
7/25/2024
Partner with ElevateBio BaseCamp to leverage the LentiPeak™ platform for high-quality, scalable lentiviral vector production and accelerate your cell and gene therapy development.